Press Releases Sign Up For Updates Year All20252024202320222021202020192018201720162015 Date Description View 01/06/25 Denali Therapeutics Announces Topline Results for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial PDF Version Pagination First page « Previous page ‹ Page 1 Current page 2 Sign up for email alerts Stay in the loop with updates on the latest Denali news delivered right to your inbox Submit Investor & Media Relations
Year All20252024202320222021202020192018201720162015 Date Description View 01/06/25 Denali Therapeutics Announces Topline Results for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial PDF Version Pagination First page « Previous page ‹ Page 1 Current page 2